Find a Doctor
With over 400 board-certified physicians, Albany Med Faculty Physicians
are some of the most expert in their field. Find the right
physicians who meet your medical needs.
Arif Asif MDChief, Division of Nephrology
American Board of Internal Medicine, 2000
AMC Nephrology Group
25 Hackett Blvd. MC 69
Albany, NY 12208
Tel: (518) 262-5176
Fax: (518) 262-5573
07/01/1998 - 06/30/2000
University of Miami-Jackson memorial Hospital
07/01/1995 - 07/01/1998
Mercy Hospital & Medical Center
09/01/1988 - 03/30/1991
Mayo Hospital-King Edward Medical College
Junior Resident Surgeon
06/23/1994 - 6/22/1995
University of Tennessee
10/01/1981 - 01/01/1988
Punjab Medical College-University of the Punjab
Dr. Asif serves as the Thomas Ordway Distinguished Professor of Medicine and Chief of Nephrology and Hypertension at Albany Medical College. He specializes in glomerular diseases, hypertension, vascular access, dialysis and acute kidney injury. Dr. Asif has established and solidified multiple programs within the division including a Hypertension Program, Kidney Donor Evaluation Program, Glomerular Diseases Program, Renal Translational Research Program, Dialysis Access Program and a strong Outpatient Dialysis Program. Dr. Asif is also the founding Program Director of Nephrology Fellowship Training Program at Albany Medical College. He is a national and an international figure in the area of Interventional Nephrology and is the Past President of the American Society of Diagnostic and Interventional Nephrology.
He has published over 120 articles in high-impact peer-reviewed journals, chaired multiple scientific meetings and has delivered over 200 lectures at national and international scientific meetings. He has received multiple awards for teaching, research and scholarly activity and excellence in patient care. He serves as an editor, editorial board member and reviewer of numerous journals in NEJM, JAMA, KI, CJASN, AJKD and Seminars in Dialysis. He has conducted both industry and NIH funded studies. His current research is focusing on various aspects of dialysis access including novel therapeutic interventions to halt neointimal hyperplasia in fistulas, biomarker identification in hypertension, peripheral vascular disease in the dialysis population, surveillance of vascular access, acute kidney injury and hypercalcemia.